Chloe Eckel

Xcel Pharmaceuticals, Inc. used to manufactures pharmaceutical products. The company was engaged in prescription products that treat disorders of the central nervous system. Its portfolio included four products, two that were used to treat epilepsy and two that were used to treat migraine. The company was founded in 2001 by Cam L. Garner and was headquartered in San Diego, CA

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs.

Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI.

DevCo Pharmaceuticals Ltd specializes in marketing, licensing, and development of prescription medicines. The private company is based in London, UK.

DFW Capital Partners (DFW Capital Partners) is a private equity firm founded in 1983 by Donald F. DeMuth. The firm is headquartered in Teaneck, New Jersey.

Citigroup Private Equity LP (Citigroup Private Equity) a Private Equity firm, a subsidiary of Citigroup Alternative Investments LLC founded in 1997. The firm is headquartered in New York.

UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA.

Alaven Pharmaceutical LLC develops and markets prescription and non-prescription products. The company was founded on August 01, 2003 and is headquartered in Somerset, NJ.

Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA.

Newstone Capital Partners LLC (Newstone Capital Partners) is an independent private equity firm founded in 2006 by Timothy P. Costello and John C. Rocchio. The firm is headquartered in Dallas, Texas.

Clinical Research Holdings LLC provides commercial physical and biological research services. The firm specializes in Phase I/IIa Clinical Pharmacology, Outpatient Studies, In-Hospital Trials, Vaccines, Complex Clinical Trials, Special populations, Phase II, Phase III and Phase IV. The company was founded in 1998 and is headquartered in DeLand, FL.

HZNP USA LLC acquires, develops, markets and distributes specialty pharmaceutical products. The firm offers Actimmune, which is a bioengineered form of interferon gamma-1b, a protein that acts as a biologic response modifier through stimulation of the human immune system. Its Actimmune product is used for reducing the frequency and severity of serious infections related to chronic granulomatous diseases, and for delaying time to disease progression in patients with severe malignant osteopetrosis. The company was founded in 2011 by Balaji K. Venkataraman and Virinder Nohria and is headquartered in Lake Forest, FL.

Sebela Pharmaceuticals, Inc. engages in the provision of marketing and selling of pharmaceutical prescription products. It specializes in the gastroenterology, dermatology, and women?s health. The company is headquartered in Roswell, GA.

Accel Clinical Services LLC provides clinical research services. It offers clinical trials in a wide range of therapeutic indications to pharmaceuticals, biotech start-ups, and contract research organizations. It conducts Phase I, In-Hospital, vaccine and outpatient Phase II-IV trials. The company was founded in 1998 and is headquartered in DeLand, FL.

Avego Healthcare Capital LLC operates as a private equity firm specializing in growth capital and late stage transactions. It invests in cycle management, under-resourced products, healthcare services, biopharmaceutical services, contract research organizations, clinical study sites, contract development organizations, contract manufacturing organizations, API manufacturing, contract packaging, niche/specialty services, unskilled home health, highly specialized procedure centers. The company was founded by Balaji K. Venkataraman in 2015 and is headquartered in Alpharetta, GA.

MRI HoldCo LLC operates as a holding firm. The company is headquartered in Alpharetta, GA.

Avanza Laboratories LLC provides pharmaceutical and agrochemical support. The company is headquartered in Gaithersburg, MD.

Saol Therapeutics Research Ltd. is an Irish company that focuses on developing novel clinical programs to change the standard of care. The company is based in Dublin, Ireland. The company's vision is to provide practical innovation, which can be seen in their pipeline. The company was founded in 2015, and David Penake has been the CEO of the company since January 01, 2016.

Eyevance Holdings LLC engages in the development of therapeutic products. The company is headquartered in Fort Worth, TX.

Saol Holdings LLC provides investment services. The company is headquartered in Roswell. GA.

Part of hyperCORE International LLP, Alcanza Clinical Research LLC is a company that operates as an integrated network of research facilities. The company is based in Lake Mary, FL. The company was founded in 2021. Carlos E. Orantes has been the CEO of the company since 2022. Alcanza Clinical Research was acquired by hyperCORE International LLP on June 28, 2022.

hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn.